See more : Grizzly Discoveries Inc. (GZDIF) Income Statement Analysis – Financial Results
Complete financial analysis of Rapid Dose Therapeutics Corp. (RDTCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rapid Dose Therapeutics Corp., a leading company in the Biotechnology industry within the Healthcare sector.
- NuZee, Inc. (NUZE) Income Statement Analysis – Financial Results
- ZACD Group Ltd. (8313.HK) Income Statement Analysis – Financial Results
- TB SA Acquisition Corp (TBSAW) Income Statement Analysis – Financial Results
- Nan Hai Corporation Limited (NANHF) Income Statement Analysis – Financial Results
- Hangzhou Lion Electronics Co.,Ltd (605358.SS) Income Statement Analysis – Financial Results
Rapid Dose Therapeutics Corp. (RDTCF)
About Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films, as well as for developing orally delivered vaccine candidate for COVID-19. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.02M | 718.30K | 1.75M | 262.81K | 101.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 457.02K | 345.89K | 407.12K | 55.35K | 64.16K | 156.28K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 563.41K | 372.40K | 1.34M | 207.45K | 37.34K | -156.28K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 55.21% | 51.85% | 76.76% | 78.94% | 36.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 427.80K | 92.89K | 359.29K | 85.31K | 272.72K | 222.35K | 12.44K | 7.24K | 5.53K | 596.00 | 7.31K | 14.31K | 15.36K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.36M | 2.95M | 4.23M | 1.34M | 6.33M | 10.86M | 37.64K | 39.86K | 46.22K | 60.02K | 21.74K | 76.54K | 52.36K | 71.11K | 532.00 | 0.00 |
| Selling & Marketing | 241.70K | 228.47K | 159.67K | 162.55K | 455.69K | 243.88K | 57.26K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.60M | 3.18M | 4.39M | 1.50M | 6.79M | 11.10M | 37.64K | 39.86K | 46.22K | 60.02K | 21.74K | 76.54K | 52.36K | 71.11K | 532.00 | 0.00 |
| Other Expenses | 1.28M | 0.00 | 8.46K | -70.00K | 90.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.30M | 3.92M | 5.65M | 2.33M | 7.54M | 11.48M | 50.08K | 47.10K | 51.74K | 60.62K | 29.05K | 76.54K | 67.72K | 79.96K | 6.81K | 3.38K |
| Cost & Expenses | 4.76M | 4.26M | 6.05M | 2.39M | 7.61M | 11.48M | 50.08K | 47.10K | 51.74K | 60.62K | 29.05K | 76.54K | 67.72K | 79.96K | 6.81K | 3.38K |
| Interest Income | 0.00 | 0.00 | 363.00 | 0.00 | 17.17K | 201.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 661.45K | 264.64K | 133.48K | 142.56K | 108.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 620.31K | 627.44K | 765.81K | 675.47K | 484.06K | 156.28K | 1.19K | 52.52K | 22.82K | -82.83K | -9.56K | 102.01K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -3.02M | -2.92M | -3.53M | -987.23K | -7.31M | -11.41M | -50.08K | -47.10K | -51.74K | -102.04K | -38.61K | 25.48K | -67.72K | -79.96K | -6.81K | -3.38K |
| EBITDA Ratio | -296.42% | -406.01% | -201.34% | -552.34% | -6,811.32% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.74M | -3.81M | -4.44M | -2.27M | -7.61M | -11.48M | -50.08K | -47.10K | -51.74K | -19.20K | -29.05K | -76.54K | -67.72K | -79.96K | -6.81K | -3.38K |
| Operating Income Ratio | -366.39% | -530.20% | -253.17% | -863.61% | -7,501.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -567.72K | -266.25K | -4.05M | -28.04K | -459.31K | 83.37K | 0.00 | 0.00 | 0.00 | 0.00 | 9.56K | -102.01K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -4.31M | -3.81M | -8.49M | -2.30M | -7.96M | -11.40M | -50.08K | -47.10K | -51.74K | -19.20K | -19.49K | -178.55K | -67.72K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -422.03% | -530.42% | -484.47% | -874.28% | -7,847.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 264.64K | 141.94K | 142.56K | 199.24K | -83.37K | -1.19K | -52.52K | -22.82K | 41.42K | 0.00 | 0.00 | 67.72K | 79.96K | 6.81K | 3.38K |
| Net Income | -4.31M | -3.81M | -8.49M | -2.30M | -7.96M | -11.40M | -50.08K | -47.10K | -51.74K | -19.20K | -19.49K | -178.55K | -67.72K | -79.96K | -6.81K | -3.38K |
| Net Income Ratio | -422.03% | -530.42% | -484.47% | -874.28% | -7,847.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.04 | -0.08 | -0.03 | -0.10 | -0.18 | -0.05 | -0.06 | -0.11 | -0.07 | -0.07 | -0.66 | -0.25 | -0.17 | -0.02 | -0.01 |
| EPS Diluted | -0.04 | -0.04 | -0.08 | -0.03 | -0.10 | -0.18 | -0.05 | -0.06 | -0.11 | -0.07 | -0.07 | -0.66 | -0.25 | -0.17 | -0.02 | -0.01 |
| Weighted Avg Shares Out | 104.96M | 103.42M | 100.22M | 77.79M | 76.09M | 62.75M | 1.11M | 804.66K | 478.39K | 270.39K | 270.39K | 270.39K | 270.39K | 481.49K | 300.00K | 300.00K |
| Weighted Avg Shares Out (Dil) | 104.96M | 103.42M | 100.22M | 77.79M | 76.09M | 62.75M | 1.11M | 804.66K | 478.39K | 270.39K | 270.39K | 270.39K | 270.39K | 481.49K | 300.00K | 300.00K |
Source: https://incomestatements.info
Category: Stock Reports